CXW · CoreCivic, Inc.
Market Cap
$3.34B
Shares
98.89M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$33.22
Open$33.51
Day$33.06–33.97
52W close$16.13–34.01
Avg vol 30d1.4M
Short int15.4M · 15.6% float · 8.7d
Short vol21%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
AI Brief
Q1 FY26 earnings call · May 6, 2026
Q1 FY26
TL;DR. CoreCivic reported strong Q1 2026 results with revenue up 25.8%, Adjusted Diluted EPS up 73.9%, and Adjusted EBITDA up 36%, driven by the activation of four previously idled facilities and higher federal demand, and the company raised full-year 2026 guidance. However, ICE populations in CoreCivic's care have declined roughly 3,000 individuals since the end of January 2026 due to DHS enforcement redeployments and strategy adjustments.
Bullish
- + Total revenue increased 25.8% versus the prior-year quarter, with net income up 51.0% to $37.9 million and Adjusted Diluted EPS up 73.9% to $0.40 new
- + Revenue from ICE increased to $128.1 million, up 96.2%, and federal partner revenue rose 48% year over year, with federal partners comprising 58% of total revenue new
- + Average daily population across managed facilities grew to 57,243 from 51,429, including 14,689 ICE individuals (up ~4,500 since the start of 2025), supported by the activation of four previously idle facilities new
- + Full-year 2026 guidance was increased, including an incremental ~$0.05–$0.06 EPS contribution from the new 1,033-bed Midwest Regional Reception Center contract new
- + Subsequent to quarter-end, CoreCivic acquired Clinical Solutions Pharmacy, one of the largest providers of mail-order pharmacy services to correctional facilities in the U.S., diversifying cash flows new
- + Repurchased 2.3 million shares for $44.7 million in the quarter, ended with net debt to Adjusted EBITDA of 2.8x, and added a $100 million incremental term loan to maintain liquidity new
Bearish
- − ICE populations in CoreCivic's care have declined by roughly 3,000 individuals since the end of January 2026 through April 30, 2026, attributed to a government shutdown centered on DHS funding, DHS leadership reorganization, and redeployment of ICE agents to TSA checkpoints new
- − Nationwide U.S. Marshals Service revenue decreased $12.2 million versus the prior quarter, and nationwide USMS populations have declined year over year, partially offsetting ICE growth new
- − DHS is potentially shifting toward converting vacant warehouses and acquiring existing turnkey facilities to meet detention needs, and the future of the warehouse strategy is uncertain new
- − New idle facility activations and contract awards are expected to be impacted by the recent ICE population decline and uncertainty around appropriations, potentially pushing new awards later in the year new
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+46%
above
Price vs 50-day avg
+5%
above
RSI (14)
55
neutral
MACD trend
Negative
52-week position
96%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
+87%
trailing
YTD return
+74%
this year
Relative strength
+74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $32 › 200d $23 — 50d above 200d
Institutional flow
Accumulating
+14% holders QoQ · +71 funds added
Insider flow
Distributing
Net -$14.7M over 90 days · 100% sells
Short interest
Rising
15.60% of float · ▲ +331.5% MoM · 8.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
279 holders — near 3-yr high, broad support
Squeeze score
72
high risk · 0–100
Fundamentals
Revenue growth
+13%
Y/Y
EPS growth
+74%
Y/Y
Valuation
P/E 27.1
rich
Buyback
$255.8M
remaining
Balance sheet
$1.1B
net debt
Quant / Vol
risk profile
Volatility
39%
annualized · 1-yr
Max drawdown
−25%
past year
ATR
4.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 6, 2026
Adjusted diluted EPS
· 2026
Non-GAAP
$1.62 – $1.70
Normalized FFO per share
· 2026
$2.61 – $2.70
Adjusted EBITDA
· 2026
Non-GAAP
$440.5M – $445.5M
Maintenance capital expenditures
· 2026
$65M – $75M
Adjusted funds from operations (AFFO)
· 2026
Non-GAAP
$257.5M – $271.5M
Capital expenditures associated with previously idle facilities
· 2026
$35M – $40M
G&A expenses
· 2026
$173M – $175M
Annual effective tax rate
· 2026
25% – 28%
Prior guidance
period ended
· from the 8-K filed Nov 6, 2024
Capital expenditures
· Full Year 2024
$70M – $76M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+46%
Bullish
Price vs 50-day avg
+5%
Bullish
RSI (14)
55
Neutral
MACD trend
Negative
Bearish
52-week position
96%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $32 › 200d $23 — 50d above 200d
Institutional flow
Accumulating
+14% holders QoQ · +71 funds added
Insider flow
Distributing
Net -$14.7M over 90 days · 100% sells
Short interest
Rising
15.60% of float · ▲ +331.5% MoM · 8.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
279 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $16
Now $33 · 96%
Range high $34
vs 200-day avg +46%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average available beds | 71,884 | the three months ended June 30, 2026 filing | — |
| Average compensated occupancy | 78.4% | the three months ended June 30, 2026 filing | — |
| Average compensated population | 56,363 | the three months ended June 30, 2026 filing | — |
| Operating margin | 22.4% | the three months ended June 30, 2026 filing | — |
| Residential segment net operating income as a percentage of total NOI | 92.4% | the three months ended June 30, 2026 filing | — |
| Revenue per compensated man-day | $119.88 | the three months ended June 30, 2026 filing | — |
| Total expenses per compensated man-day | $93.05 | the three months ended June 30, 2026 filing | — |
| Variable expenses per compensated man-day | $24.78 | the three months ended June 30, 2026 filing | — |
| Adjusted Diluted EPS non-GAAP | $0.38 | Second Quarter 2026 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | 219.56M | Six Months Ended June 30 | — |
|
|
|||
| Normalized FFO per diluted share non-GAAP | $0.64 | Second Quarter 2026 | — |
|
|
|||
| Occupancy levels in Residential segment | 78.4% | the second quarter of 2026 | — |
| Facility operating margin | 24% | first quarter 2026 | — |
| Funds from Operations Per Diluted Share non-GAAP | $0.64 | Q1 2026 | — |
|
|
|||
| Normalized FFO non-GAAP | $65.1M | first quarter 2026 | — |
| Revenue from ICE | $261.3M | first quarter 2026 | — |
| Safety and Community segments occupancy | 79.6% | first quarter 2026 | — |
| EBITDA non-GAAP | 362.12M | Twelve Months Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Net income 116.5M
+76.04M Interest expense
+128.91M Depreciation and amortization
+40.67M Income tax expense
= EBITDA 362.12M
|
|||
| Funds From Operations non-GAAP | 218.22M | Twelve Months Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Net income 116.5M
+101.37M Depreciation and amortization of real estate assets
+1.48M Impairment of real estate assets
-1.01M Loss (gain) on sale of real estate assets, net
-127K Income tax expense (benefit) for special items
= Funds From Operations 218.22M
|
|||
| Normalized Funds From Operations non-GAAP | 220.4M | Twelve Months Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Funds From Operations 218.22M
+0K Expenses associated with debt repayments and refinancing transactions
+3.02M Expenses associated with mergers and acquisitions
+0K Other asset impairments
-837K Income tax benefit for special items
= Normalized Funds From Operations 220.4M
|
|||
| Safety and Community segments combined occupancy | 78.1% | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Security & Protection Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CXW
this stock
CoreCivic, Inc.
|
$3.34B | +73.8% | +12.7% | 27.1 | 15.6% |
|
ALLE
Allegion plc
|
$13.20B | -2.5% | +7.6% | 20.4 | 4.6% |
|
MSA
MSA Safety Inc
|
$7.34B | +18.9% | +3.7% | 23.7 | 2.6% |
|
ADT
ADT Inc.
|
$5.40B | -8.4% | +4.7% | — | 3.6% |
|
BCO
Brinks Co
|
$4.49B | -6.7% | -5.7% | 25.2 | 11.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CXW | -1.8% | +9.6% | +87.5% | +11.1% | +73.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -2.3% | +6.7% | +74.0% | +8.1% | +61.0% |
Capital returns
Latest dividend
$0.44
/ share · ex Mar 31, 2020
Paid (TTM)
$0.00
/ share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Buyback programs
· 3 active
· as of Aug 10, 2026
Authorized (total)
$2.40B
Spent (derived)
$2.14B
Remaining
$255.80M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1070985
CUSIP
21871N101
13F (30d)
230 filings
226 filers
Visit website
Investor relations